The vaginal and gastrointestinal microbiomes in gynecologic cancers: a review of applications in etiology, symptoms and treatment. (Q35625903)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25957158%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

review article

1 reference

title

The vaginal and gastrointestinal microbiomes in gynecologic cancers: a review of applications in etiology, symptoms and treatment (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25957158%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

0 references

Melissa M Herbst-Kralovetz

series ordinal

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25957158%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

3

Frederic Zenhausern

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25957158%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

4

Bradley Monk

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25957158%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

author name string

Dana Chase

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25957158%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Alison Goulder

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25957158%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

language of work or name

English

0 references

publication date

5 May 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25957158%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25957158%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

volume

138

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25957158%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25957158%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

page(s)

190-200

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25957158%20AND%20SRC:MED&resulttype=core&format=json

Vaginal microbiome of reproductive-age women

7 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.04.036

Vaginal microbiome: rethinking health and disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.04.036

Characteristics of 454 pyrosequencing data--enabling realistic simulation with flowsim

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.04.036

16S rRNA gene sequencing for bacterial identification in the diagnostic laboratory: pluses, perils, and pitfalls

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.04.036

Gut microbiota, immunity, and disease: a complex relationship

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.04.036

Understanding the role of gut microbiome-host metabolic signal disruption in health and disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.04.036

The microbiome and cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.04.036

Factors associated with grade 3 or 4 treatment-related toxicity in women with advanced or recurrent cervical cancer: an exploratory analysis of NRG Oncology/Gynecologic Oncology Group trials 179 and 204.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.04.036

Fecal microbiota transplantation for recurrent C difficile infection: ready for prime time?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.04.036

Overview of high-risk HPV's 16 and 18 infected cervical cancer: pathogenesis to prevention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.04.036

Interplay between the temporal dynamics of the vaginal microbiota and human papillomavirus detection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.04.036

Comparison of the vaginal microbiota diversity of women with and without human papillomavirus infection: a cross-sectional study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.04.036

A large, population-based study of age-related associations between vaginal pH and human papillomavirus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.04.036

Association of the vaginal microbiota with human papillomavirus infection in a Korean twin cohort

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.04.036

Gastrointestinal complications of pelvic radiotherapy: are they of any importance?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.04.036

The prevalence of chronic radiation enteritis following radiotherapy for cervical or endometrial cancer and its impact on quality of life.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.04.036

Impact of pelvic radiotherapy on gut microbiota of gynecological cancer patients revealed by massive pyrosequencing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.04.036

Obesity, diabetes, and gut microbiota: the hygiene hypothesis expanded?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.04.036

Invasive potential of gut mucosa-derived Fusobacterium nucleatum positively correlates with IBD status of the host.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.04.036

Reversal of visceral and cutaneous hyperalgesia by local rectal anesthesia in irritable bowel syndrome (IBS) patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.04.036

Sensitization of pelvic nerve afferents and mast cell infiltration in the urinary bladder following chronic colonic irritation is mediated by neuropeptides.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.04.036

Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.04.036

Gut feelings: the emerging biology of gut-brain communication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.04.036

Summation model of pelvic pain in interstitial cystitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.04.036

Vaginal changes and sexuality in women with a history of cervical cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.04.036

Sexuality and sexual function in long-term survivors of cervical cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.04.036

Microbiota and pelvic inflammatory disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.04.036

A cluster analysis of bacterial vaginosis-associated microflora and pelvic inflammatory disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.04.036

Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.04.036

A core gut microbiome in obese and lean twins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.04.036

Energy-balance studies reveal associations between gut microbes, caloric load, and nutrient absorption in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.04.036

Association between the vaginal microbiota, menopause status, and signs of vulvovaginal atrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.04.036

Microbiome and malignancy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.04.036

The wedelolactone derivative inhibits estrogen receptor-mediated breast, endometrial, and ovarian cancer cells growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.04.036

Endometrial cancer and estrogen use. Report of a large case-control study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.04.036

Hormone replacement therapy and endometrial cancer risk: a meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.04.036

Contemporary clinical management of endometrial cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.04.036

A systematic review of quality of life and sexual function of patients with cervical cancer after treatment.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.04.036

Vaginal microbiome and epithelial gene array in post-menopausal women with moderate to severe dryness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.04.036

Development of an ovarian cancer symptom index: possibilities for earlier detection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.04.036

Frequency of symptoms of ovarian cancer in women presenting to primary care clinics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.04.036

Ovarian carcinoma diagnosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.04.036

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.04.036

Changes in short-term health-related quality of life in women undergoing gynecologic oncologic laparotomy: an associated factor analysis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.04.036

A prospective study of circulating C-reactive protein, interleukin-6, and tumor necrosis factor α receptor 2 levels and risk of ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.04.036

The genital flora of women with intraamniotic infection. Vaginal Infection and Prematurity Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.04.036

Evidence relating bacterial vaginosis to intraamniotic infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.04.036

The role of bacterial vaginosis and vaginal bacteria in amniotic fluid infection in women in preterm labor with intact fetal membranes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.04.036

Role of bacterial vaginosis-associated microorganisms in endometritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.04.036

Colonization of the upper genital tract by vaginal bacterial species in nonpregnant women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.04.036

Palliative chemotherapy for malignant ascites secondary to ovarian cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.04.036

The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.04.036

Commensal bacteria control cancer response to therapy by modulating the tumor microenvironment.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.04.036

Noninvasive nutritional management of ovarian cancer patients: beyond intestinal obstruction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.04.036

Gut barrier dysfunction and microbial translocation in cancer cachexia: a new therapeutic target

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.04.036

Muscle wasting: the gut microbiota as a new therapeutic target?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.04.036

Toll-like receptors differentially regulate CC and CXC chemokines in skeletal muscle via NF-kappaB and calcineurin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.04.036

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.04.036

Restoring specific lactobacilli levels decreases inflammation and muscle atrophy markers in an acute leukemia mouse model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.04.036

Use of probiotics for prevention of radiation-induced diarrhea

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.04.036

Randomized controlled trial of live lactobacillus acidophilus plus bifidobacterium bifidum in prophylaxis of diarrhea during radiotherapy in cervical cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.04.036

A randomized double-blind controlled trial: impact of probiotics on diarrhea in patients treated with pelvic radiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.04.036

Effects of probiotic Lactobacillus casei DN-114 001 in prevention of radiation-induced diarrhea: results from multicenter, randomized, placebo-controlled nutritional trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.04.036

Antimicrobial peptides in the female reproductive tract: a critical component of the mucosal immune barrier with physiological and clinical implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.04.036

Exploring a road map to counter misconceptions about the cervicovaginal microbiome and disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.04.036

Lactobacillus reuteri-produced cyclic dipeptides quench agr-mediated expression of toxic shock syndrome toxin-1 in staphylococci

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.04.036

Disruption of urogenital biofilms by lactobacilli

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.04.036

Lactobacillus rhamnosus GR-1 and L. reuteri RC-14 to prevent or cure bacterial vaginosis among women with HIV.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.04.036

Randomized, placebo-controlled phase 2 trial of a Lactobacillus crispatus probiotic given intravaginally for prevention of recurrent urinary tract infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.04.036

Effects of probiotics for the treatment of bacterial vaginosis in adult women: a meta-analysis of randomized clinical trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.04.036

Augmentation of antimicrobial metronidazole therapy of bacterial vaginosis with oral probiotic Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14: randomized, double-blind, placebo controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.04.036

Improved cure of bacterial vaginosis with single dose of tinidazole (2 g), Lactobacillus rhamnosus GR-1, and Lactobacillus reuteri RC-14: a randomized, double-blind, placebo-controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.04.036

Effectiveness of Lactobacillus-containing vaginal tablets in the treatment of symptomatic bacterial vaginosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.04.036

Efficacy of vaginal probiotic capsules for recurrent bacterial vaginosis: a double-blind, randomized, placebo-controlled study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.04.036

Antiviral activity of Bifidobacterium adolescentis SPM1005-A on human papillomavirus type 16.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.04.036

Normal and tumour cervical cells respond differently to vaginal lactobacilli, independent of pH and lactate.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.04.036

Probiotics enhance the clearance of human papillomavirus-related cervical lesions: a prospective controlled pilot study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.04.036

Lactobacillus species as opportunistic pathogens in immunocompromised patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.04.036

Lactobacillus sepsis associated with probiotic therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.04.036

Safety of probiotics: translocation and infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.04.036

The administration of probiotics and synbiotics in immune compromised adults: is it safe?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.04.036

Bacteria in the vaginal microbiome alter the innate immune response and barrier properties of the human vaginal epithelia in a species-specific manner

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.04.036

Efficacy of prebiotics, probiotics, and synbiotics in irritable bowel syndrome and chronic idiopathic constipation: systematic review and meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.04.036

10.1016/J.YGYNO.2015.04.036

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25957158%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

1 reference